Literature DB >> 14887769

Therapeutic value of salpingograms in infertility.

W C WEIR, D R WEIR.   

Abstract

Entities:  

Keywords:  FALLOPIAN TUBES; STERILITY, FEMALE/therapy

Mesh：

Year:  1951        PMID： 14887769     DOI： 10.1016/s0015-0282(16)30725-7

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


× No keyword cloud information.
  5 in total

Review 1.  Tubal flushing for subfertility.

Authors:  Lamiya Mohiyiddeen; Anne Hardiman; Cheryl Fitzgerald; Edward Hughes; Ben Willem J Mol; Neil Johnson; Andrew Watson
Journal:  Cochrane Database Syst Rev       Date:  2015-05-01

2.  THE USE OF HYSTEROSALPINGOGRAPHY IN THE DIAGNOSIS OF INFERTILITY AND OTHER GYNECOLOGICAL CONDITIONS.

Authors:  W A DUTTON; J G STAPLETON
Journal:  Can Med Assoc J       Date:  1963-12-07       Impact factor: 8.262

3.  Tubal flushing with oil- or water-based contrast medium: can we identify markers that indicate treatment benefit?

Authors:  Joukje van Rijswijk; Nienke van Welie; Kim Dreyer; Parvin Tajik; Cornelis B Lambalk; Peter Hompes; Velja Mijatovic; Ben W J Mol; Mohammad H Zafarmand
Journal:  Hum Reprod Open       Date:  2019-07-18

4.  Live birth after additional tubal flushing with oil-based contrast versus no additional flushing: a randomised, multicentre, parallel-group pragmatic trial in infertile women with at least one patent tube at hysterosalpingo-foam sonography (HYFOIL study).

Authors:  Diane De Neubourg; Lara Janssens; Iris Verhaegen; Elke Smits; Ben W Mol; Ella Roelant
Journal:  BMJ Open       Date:  2021-11-29       Impact factor: 2.692

5.  Treatment effect of oil-based contrast is related to experienced pain at HSG: a post-hoc analysis of the randomised H2Oil study.

Authors:  N van Welie; K Dreyer; J van Rijswijk; H R Verhoeve; M Goddijn; A W Nap; J M J Smeenk; M A F Traas; H G M Rijnsaardt-Lukassen; A J C M van Dongen; P Bourdrez; J P de Bruin; A V Sluijmer; A P Gijsen; P M van de Ven; C B Lambalk; V Mijatovic; B W J Mol
Journal:  Hum Reprod       Date:  2019-12-01       Impact factor: 6.918
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.